RecruitingPhase 2NCT04301765

Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency

Sponsor

Seattle Institute for Biomedical and Clinical Research

Enrollment

230 participants

Start Date

Jan 12, 2021

Study Type

INTERVENTIONAL

Conditions

Cancer Fatigue Hypogonadism, Male

Summary

This is a large randomized, double-blind, placebo-controlled trial to determine the efficacy of testosterone replacement on cancer-related fatigue in older men with solid or hematologic (blood) cancer who report fatigue and have low testosterone levels.

Eligibility

Sex: MALEMin Age: 55 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying placebo gel and a drug called testosterone 1.62% gel for people with cancer, fatigue, and other related conditions. The study is currently recruiting participants at 3 locations. People eligible for this study include men aged 55 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGtestosterone 1.62% gel

The gel will be applied daily by the participants (all participants will be trained in the application process and will be given printed instructions). The intervention will be for 6 months

OTHERplacebo gel

The gel will be applied daily by the participants (all participants will be trained in the application process and will be given printed instructions). The intervention will be for 6 months